about
Prognostic models for chronic lymphocytic leukaemia: an exemplar systematic review and meta-analysisNodal and leukemic small B-cell neoplasmsEvolution of multiple cell clones over a 29-year period of a CLL patientMDM2 promotor polymorphism and disease characteristics in chronic lymphocytic leukemia: results of an individual patient data-based meta-analysisThe role of ATM mutations and 11q deletions in disease progression in chronic lymphocytic leukemia.Copy neutral loss of heterozygosity in 20q in chronic lymphocytic leukemia/small lymphocytic lymphoma.A case of comorbid myxoma and chronic lymphocytic leukemia: not just a coincidence?microRNA-34b/c on chromosome 11q23 is aberrantly methylated in chronic lymphocytic leukemiaAcquired chromosomal anomalies in chronic lymphocytic leukemia patients compared with more than 50,000 quasi-normal participants.Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrest.Development of a comprehensive prognostic index for patients with chronic lymphocytic leukemia.OSU-T315: a novel targeted therapeutic that antagonizes AKT membrane localization and activation of chronic lymphocytic leukemia cellsTelomere length and telomerase levels delineate subgroups of B-cell chronic lymphocytic leukemia with different biological characteristics and clinical outcomes.Toward personalized therapy for chronic lymphocytic leukemia: DSC and cDNA microarray assessment of two cases.Detection of chromothripsis-like patterns with a custom array platform for chronic lymphocytic leukemia.Combined patterns of IGHV repertoire and cytogenetic/molecular alterations in monoclonal B lymphocytosis versus chronic lymphocytic leukemiaChronic lymphocytic leukemia: molecular heterogeneity revealed by high-throughput genomicsLoss of p53 and altered miR15-a/16-1MCL-1 pathway in CLL: insights from TCL1-Tg:p53(-/-) mouse model and primary human leukemia cells.Targeting p53-deficient chronic lymphocytic leukemia cells in vitro and in vivo by ROS-mediated mechanism.Treating chronic lymphocytic leukemia with thalidomide and lenalidomide.Exploiting inhibitor of apoptosis proteins as therapeutic targets in hematological malignancies.Can prognostic factors be used to direct therapy in chronic lymphocytic leukemia?RNA-based markers as prognostic factors in chronic lymphocytic leukemia.Present status and perspectives in functional analysis of p53 in chronic lymphocytic leukemia.The role of high-dose corticosteroids in the treatment of chronic lymphocytic leukemia.The role of bone marrow biopsy examination at diagnosis of chronic lymphocytic leukemia: a reappraisal.Inhibitor of Apoptosis (IAP) proteins in hematological malignancies: molecular mechanisms and therapeutic opportunities.Metadherin contributes to the pathogenesis of chronic lymphocytic leukemia partially through Wnt/β-catenin pathway.CD1d expression as a prognostic marker for chronic lymphocytic leukemia.Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic clone.Section E6.1-6.4 of the ACMG technical standards and guidelines: chromosome studies of neoplastic blood and bone marrow-acquired chromosomal abnormalities.Chronic lymphocytic leukemia with a t(8;14)(q24;q32): FISHing catches a (sheepish) red herring.Telomere shortening, TP53 mutations and deletions in chronic lymphocytic leukemia result in increased chromosomal instability and breakpoint clustering in heterochromatic regions.Biallelic ATM alterations detected at diagnosis identify a subset of treatment-naïve chronic lymphocytic leukemia patients with reduced overall survival similar to patients with p53 deletion.Rapid detection of ATM/p53 function with p27Kip FACS analysis: a novel diagnostic tool for chronic lympocytic leukemia?Actinomycin D induces p53-independent cell death and prolongs survival in high-risk chronic lymphocytic leukemiaFludarabine-resistance associates with ceramide metabolism and leukemia stem cell development in chronic lymphocytic leukemia
P2860
Q24186840-2190BD6A-2A17-4A0E-B223-89603FC151E3Q26829315-22727437-12E6-46D9-A0DD-9250676F93ADQ28396836-5679FE79-BA7E-4827-B513-6553A39D6F45Q30840070-E1E68937-31DD-49C9-AD13-848CD9BC57CAQ33409459-A4EBFAB7-D3EF-4E94-BCCF-9D3793451C53Q33567169-E86E6F44-188E-4C72-A978-C400F71D22F0Q33608998-5B680C78-EF1D-48FD-9CCF-90082E06C589Q33740606-82A7A2D8-99ED-4C58-869A-A0C196BA3D3EQ33818637-E70D197F-ACFA-4FEF-B730-2EF57E821BCBQ34329286-347BB5E8-0DA9-4326-86FF-1E3D783FFEB0Q34418874-8236DD8C-E294-4B81-8FAC-F7CCA55B9732Q34876742-5ED9F77E-5A3A-4448-BE33-8A834F8EFD3CQ35643026-0A576951-A8B1-464C-AB7B-74BF333E03D6Q36591941-4FE0212D-B51C-48A0-8DB2-B80920F801F8Q36799831-A2E09B8E-41E0-4F2E-9029-AC6633F0C47AQ36981193-B020CD1F-3FCA-4223-9517-F9859580E610Q36998431-A376F2E7-E0AD-42B6-94BC-816DEC813113Q37251592-8D73FDA8-E5E7-48AF-B5D5-49F7293FAA07Q37687622-FE501534-778A-4EF5-95EB-9DF08122CD84Q37958036-1EB5E713-89FC-4F88-8A2A-3F60C97197A8Q37974461-8F584010-E21A-4265-A23F-A767A315AE6BQ37975154-F3DD612C-3783-4D15-AD90-09DEF0EA0AB4Q37978344-0FA14A83-7A4B-4CC9-908F-D7146BA47409Q37978967-70BB6437-E103-447C-90FA-7A1E3400D046Q38012165-1697BAF7-AA27-4BD8-8FF8-37EE8D7C2F08Q38088852-97E2C1AE-A64F-4C31-BF19-027AF5176112Q38184343-AFE4F6BD-A660-4BA4-859B-4B1DFA941090Q38921580-C12151E5-9E48-4179-91CA-5D79975783A2Q44020427-9D98EFA6-AA04-4E66-B026-A53807A94A33Q45988365-08359648-268D-4BA4-AA90-BFA257A2DE9CQ46087353-4350A7CE-2E8B-46B2-9682-964511BD53EBQ50447419-DB7F9BCD-A695-4230-89F9-0CA978F6904DQ50900368-D9144157-4BEA-4477-B5ED-8D518CF41AAEQ51587472-2F7354EA-B0C3-429D-9FB0-C4DF9FC192FBQ52853242-0DE6C5F7-2178-4922-A222-F0BF1CC56B60Q57229768-7799D5DA-3161-41D0-8734-06722E08DF72Q58764409-A38736EA-4214-445F-97E2-A484991EEA6A
P2860
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 23 March 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Importance of genetics in chronic lymphocytic leukemia.
@en
Importance of genetics in chronic lymphocytic leukemia.
@nl
type
label
Importance of genetics in chronic lymphocytic leukemia.
@en
Importance of genetics in chronic lymphocytic leukemia.
@nl
prefLabel
Importance of genetics in chronic lymphocytic leukemia.
@en
Importance of genetics in chronic lymphocytic leukemia.
@nl
P50
P1433
P1476
Importance of genetics in chronic lymphocytic leukemia.
@en
P2093
Daniel Mertens
P304
P356
10.1016/J.BLRE.2011.02.002
P577
2011-03-23T00:00:00Z